ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002